Call for research grants 2023/2024 pending ressolution

Bianual scholarships

Biannual grant for the study of colorectal cancer in terms of carcinogenesis mechanisms, prevention factors, disease progression, identification of new molecular lines, assessment of molecular variables to drug response, epidemiology, prognostic pathological factors, chemoprevention and new therapeutic approaches.

Grants granted:

2022/2023

Josep Bombardó Navinés. Established researchers

Dr. Sonia Forcales Fernández

Chromatin Dynamics in Cancer and Cell fate. Facultat de Medicina. Universitat de Barcelona

Identification and characterization of novel chromatin-targeting compounds that synergize with chemotherapy to overcome resistance in metastatic colorectal cancer.

Total amount: 60.000 €

Dionís Torres Segura. Emerging researchers

Dr. Joffrey Pelletier

Laboratori Colorectal Cancer. Fundació Institut de Recerca Biomèdica (IRB Barcelona

“Targeting ribosomal biogenesis and cell autonomous inflammation as a novel differentiation therapy in colorectal càncer”.

Total amount: 60.000 €

2021/2022

Type A. Established researchers

Dr. Manel Esteller Badosa

Josep Carreras Leukaemia Research Institute. IJC. Badalona

Deciphering the epigenomic signature induced by the carcinogenic pks+E.coli and its role in colorectal tumorigenesis.

Total amount: 60.000 €

Type B. Emerging researchers

Drª Ceres Fernández Rozadilla

Fundación Instituto de Investigación Sanitaria de Santiago de Compostela. (IDIS). Fundacion Pública Galega de Medicina Xenómica. Santiago de Compostela.

Omic-wide colorectal cancer risk deciphering the missing heritability -COALESCE.”

Total amount: 60.000 €

2020/2021

Type A. Established researchers

Dr. Eduard Batlle Gòmez

Institut de Recerca Biomèdica. IRB Barcelona. Barcelona

“Myeloid cell regulation of immune evasion in colorectal càncer.”

Total amount: 60.000 €

Type B. Emerging researchers

Dr. Alvaro Teijeira Sánchez

Fundación para la Investigación Médica Aplicada. FIMA. Pamplona (Navarra).

“Spatiotemporal dynamics of antitumor and pro-tumor immune responses in nascent and evolving colorectal cancer metastases to the liver.”

Total amount: 60.000 €

2019/2020

Type A. Established researchers

Dr. Antonio Postigo

Institut d’Investigacions Biomèdiques August Pi i Sunyer. IDIBAPS. Barcelona.

“Metabolic cooperation and competition between colorectal carcinomas (CRC) and their tumor microenvironment: Validation of ZEB factors as prognostic and predictive biomarkers and metabolic therapeutic targets in CRC.”

Total amount: 60.000 €

Type B. Emerging researchers

Dr. Ricky Shantilal Joshi

Josep Carreras Leukaemia Research Institute. IJC. Badalona.

“Studying the Clinical Impact of the Epitranscriptome for Colorectal Cancer Initiation, Progression and Treatment”

Total amount: 60.000 €

2018/2019

Type A. Established researchers

Drª Laura Valle Velasco

Institut Català d’Oncologia Institut d’Investigació Biomèdica de Bellvitge. ICO/IDIBELL. L’Hospitalet de Llobregat.

“Platform based on CRISPR/Cas-9-edited organoids for the functional evaluation of gene variants in colorectal cancer.”

Total amount: 60.000 €

Type B. Emerging researchers

Drª Ceres Fernàndez Rozadilla

Fundacion Pública Galega de Medicina Xenómica. Santiago de Compostela

“Novel liquid biopsy approaches to improve screening strategies for colorectal polyps and cancer.”

Total amount: 60.000 €

2017/2018

Type A. Established researchers

Dr. Manel Esteller Badosa

Institut d’Investigació Biomèdica de Bellvitge. IDIBELL. L’Hospitalet de Llobregat

Bioinformatic prediction of chemosensitive profiles in colorectal cancer using Epigenomics.

Total amount: 60.000 €

Type B. Emerging researchers

Dr. Rodrigo de Almeida Toledo

Institut d’Investigació Oncològica Vall d’Hebron. VHIO. Barcelona

“Evaluation of clonal evolution and changes in molecular dynamics evolution of colorectal cancers in patient’s blood.”

Total amount: 60.000 €

2016/2017

Type A. Established researchers

Dr. Eduard Batlle Gómez

Fundació Institut de Recerca Biomèdica. (IRB Barcelona)

“Evaluating immunotherapies in a preclinical model of metastatic colorectal cancer.”

Total amount: 60.000 €

Type B. Emerging researchers

Dr. Francesco Paolo Marchese

Center of Applied Medicine. (CIMA. Universidad de Navarra. Pamplona).

“Understanding the role of growth factors and nutrients in inflammatory bowell disease and colon cancer.”

Total amount: 60.000 €

2015/2016

Drª. Sonia-Vanina Forcales Fernández

Institut de Medicina Predictiva i Personalitzada del Càncer (IMPPC- Badalona)

“Identification of chromatin biomarkers for predicting and sensitizing response to current treatments in colorectal cancer.”

Total amount: 60.000 €

Dr. Nabil Djouder

Centro Nacional de Investigaciones Oncológicas (CNIO- Madrid)

“Understanding the role of growth factors and nutrients in inflammatory bowell disease and colon cancer.”

Total amount: 60.000 €

2014/2015

Drª. Raquel Batlle

Institute for Research in Biomedicine (IRB Barcelona)

“Contribution of p38 MAPK signaling to colitis-associated colorectal tumorigenesis.”

Total amount: 60.000 €

Dr. Holger Heyn

Institut d’Investigació Biomèdica de Bellvitge IDIBELL

“Systems Colorectal Cancer Genomics”

Total amount: 60.000 €

2013/2014

Drª. Enza Lonardo

Institute for Research in Biomedicine (IRB Barcelona)

“Molecular characterization and targeted elimination of the TGF-beta-driven metastasis niche by colorectal cancer vstem cells (CRC-SCs)”

“Molecular characterization and targeted elimination of the TGF-beta-driven metastasis niche by colorectal cancer vstem cells (CRC-SCs).”

Total amount: 60.000 €

Drª. Mireia Jordà Ramos

Institut de Medicina Predictiva i Personalitzada del Càncer. IMPPC

“Disruption of repeat DNA epigenetic signatures as an oncogenic mechanism: uncovering a new source of biomarkers in colorectal cancer”

“Disruption of repeat DNA epigenetic signatures as an oncogenic mechanism: uncovering a new source of biomarkers in colorectal cancer.”

Total amount: 60.000 €

2012/2013

Drª. Anna Martínez Cardús

Grup d’Epigenètica del càncer. IDIBELL

“Study of epigenetic modifications at the onset of liver metastases. Potential applicability as predictive factors of relapse”

Total amount: 60.000 €

Drª. Jelena Urosevic

Institute for Research in Biomedicine (IRB Barcelona)

“Identification and characterization of genes associated with metastasis of colorectal cancer”

Total amount: 60.000 €

2011/2012

Drª. Anna Merlos Suàrez

Institute for Research in Biomedicine (IRB Barcelona)

“Mother cells in colorectal cancer: Characterization and therapeutic approach”

Total amount: 60.000 €

Drª. Marta Crous Bou

Biomarker and susceptibility Unit. IDIBELL

“Validation of new biomarkers for preventive diagnosis of colorectal cancer”

Total amount: 60.000 €

2010/2011

Drª. Clara Ruiz Ponte

Fundación Pública Galega de Medicina Xenómica. Santiago de Compostela

“Nine genetic variants of susceptibility to colorectal cancer: pangenomic association study, replication of results and correlation with clinical variables”

Total amount: 60.000 €

Drª. Meritxell Gironella Cos

Grup CIBERehd. (Hospital Clínic. Barcelona)

“Analysis of expression profiles of microRNAs in the non-invasive diagnosis of colonic neoplastic lesions”

Total amount: 60.000 €

2009/2010

Drª. María Verónica Dávalos Vega

Grup d’Epigenètica del càncer. IDIBELL, Hospital Duran i Reynals. (L’Hospitalet de Llobregat)

“Study on the relationship between epigenome and microRNAs in colorectal cancer”

Total amount: 60.000 €.

Dr. Antonio Postigo

Grup IDIBAPS (Hospital Clínic. Barcelona)

“Transcriptional regulation of E-cadherin and invasive and metastatic capacity of tumours of the colon”

Total amount: 60.000 €

2008/2009

Dr. Stephan Tenbaum

Stem Cell and Cancer Research Group. Institut d’Oncologia Vall d’Hebron (VHIO, Barcelona)

“Tumor stem cells in cancer of the colon.”

Total amount: 60.000 €

Drª. Eva Martínez Balibrea

Laboratory Research Group of the Research Institute in Health Sciences. Hospital Universitari Germans Trias i Pujol (ICO-Badalona)

“Study of the role of pyruvate kinase m2 isoform (PK-M2) in the response and resistence to exaliplatine in cells lines and patients with advanced colorectal cancer”

Total amount: 60.000 €

2007/2008

Dr. Sergi Castellví Bel

Gastrointestinal Oncology Group (Hospital Clínic. Barcelona)

“Susceptibility polymorphisms to colorectal cancer: Characterisation of common genetic and low penetrance in chromosomal region components 3q21-q35”

Total amount: 60.000 €.

2006/2007

Team led by Professor Dr Josep Mª Ramon

Hospital de Bellvitge (L’Hospitalet de Llobregat)

“D Vitamin and colorectal cancer.”

Total amount: 36.000 €

2005/2006

Team led by Professor Dr Mariano Monzó

Hospital Clínic (Barcelona)

“Study of marker Stem cells in colorectal cancer”

Total amount: 36.000 €